Author Correction: The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions

Affiliations

• ¹ Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
• ² Institute of Experimental Cardiology, University Hospital, Heidelberg, Germany.
• ³ Institute for Biomedical Engineering and Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Zurich, Zurich, Switzerland.
• ⁴ Institute for Biomedical Engineering, Department of Information Technology and Electrical Engineering, ETH Zurich, Zurich, Switzerland.
• ⁵ Zurich integrative Rodent Physiology, University of Zurich, Zurich, Switzerland.
• ⁶ Institute of Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland.
• ⁷ Cardiopathology, Institute for Pathology and Neuropathology, University Hospital Tubingen, Tubingen, Germany.
• ⁸ Internal Medicine II, Division of Rheumatology, University Hospital Tubingen, Tubingen, Germany.
• ⁹ Department of Clinical Immunology, Jagiellonian University Medical College, Krakow, Poland.
• ¹⁰ Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. gabriela.kania@uzh.ch.